Nava Zisapel

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
RAMOT AT TEL-AVIV UNIVERSITY LTD.
2
2008
Kureha Kagaku Kogyo Kabushiki Kaisha
1
2001
NEURIM PHARMACEUTICALS
1
1
1995
2002
NEURIM PHARMACEUTICALS (1991) LTD.
2
1
1
1
1
2
3
2
6
3
2
2
2
1
3
2
1993
1994
1995
1997
2000
2001
2002
2003
2004
2005
2007
2008
2011
2012
2014
2015

Inventor Addresses

AddressDuration
23 Kissufim St., Tel Aviv, ILNov 14, 89 - Nov 14, 89
Tel Aviv, ILMar 12, 96 - Feb 20, 25
Tel-Aviv, ILFeb 13, 14 - Feb 13, 14

Technology Profile

Technology Matters
A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 1
A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 1
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 32

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
2025/0057,8482025GAL475 COMPOSITIONS AND METHODS OF USE THEREOF0
2024/0238,2502024METHOD OF USING PIROMELATINE FOR TREATING PARASOMNIAS ASSOCIATED WITH LOSS OF REM SLEEP ATONIA0
2024/0130,9682024METHODS AND PRODUCTS FOR TREATING SUBJECTS WITH AUTISM SPECTRUM DISORDERS0
2024/0068,0352024METHOD FOR DIAGNOSING AND TREATING SUBJECTS HAVING SINGLE NUCLEOTIDE POLYMORPHISMS IN CHROMOSOME 2, 2:107,510,000-107,540,000 LOCUS0
118407312023Method for diagnosing and treating subjects having single nucleotide polymorphisms in chromosome 2, 2:107,510,000-107,540,000 locus0

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.